Status:
COMPLETED
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Influenza
Eligibility:
All Genders
3-64 years
Phase:
PHASE3
Brief Summary
This protocol is designed to evaluate safety, clinical tolerability and immunogenicity of the 2007 southern hemisphere formulation of a Novartis conventional influenza vaccine licensed in the EU and m...
Eligibility Criteria
Inclusion
- Healthy subjects 3 to 64 years of age
Exclusion
- Receipt of other investigational products within 3 months or other vacine within 1 month;
- Allergy to eggs, egg products, or any other vaccine component;
- Laboratory confirmed influenza disease within 6 months;
- Have previously received an influenza vaccination (3 to 8 years only);
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
1893 Patients enrolled
Trial Details
Trial ID
NCT00464672
Start Date
April 1 2007
End Date
December 1 2007
Last Update
October 1 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 2: C1425AWK
Buenos Aires, Argentina
2
Site 1: X5000BJH
Córdoba, Argentina